Zykadia is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education